Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 4 studies | 27% ± 11% | |
astrocyte | 3 studies | 32% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 40% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3473.96 | 1445 / 1445 | 100% | 19.02 | 183 / 183 |
pancreas | 100% | 2892.27 | 328 / 328 | 100% | 31.06 | 178 / 178 |
stomach | 100% | 4505.83 | 359 / 359 | 100% | 19.59 | 286 / 286 |
uterus | 100% | 4083.45 | 170 / 170 | 100% | 22.47 | 459 / 459 |
skin | 100% | 2970.11 | 1808 / 1809 | 100% | 21.42 | 472 / 472 |
brain | 100% | 2516.73 | 2638 / 2642 | 100% | 20.40 | 705 / 705 |
thymus | 100% | 2935.43 | 653 / 653 | 100% | 23.43 | 604 / 605 |
intestine | 100% | 6275.34 | 966 / 966 | 100% | 21.62 | 526 / 527 |
liver | 100% | 1660.76 | 226 / 226 | 100% | 16.46 | 405 / 406 |
kidney | 100% | 4201.73 | 89 / 89 | 100% | 14.61 | 898 / 901 |
breast | 100% | 2159.51 | 459 / 459 | 100% | 17.11 | 1114 / 1118 |
ovary | 100% | 2413.50 | 180 / 180 | 100% | 11.72 | 428 / 430 |
lung | 100% | 3874.20 | 576 / 578 | 100% | 18.34 | 1153 / 1155 |
bladder | 100% | 3612.81 | 21 / 21 | 99% | 25.71 | 501 / 504 |
prostate | 100% | 3651.20 | 245 / 245 | 99% | 16.18 | 499 / 502 |
adrenal gland | 100% | 3919.16 | 258 / 258 | 99% | 15.41 | 228 / 230 |
adipose | 100% | 2027.89 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 19.72 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 37.34 | 29 / 29 |
spleen | 100% | 9331.06 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.33 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.40 | 1 / 1 |
blood vessel | 100% | 2289.32 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 4517.27 | 913 / 929 | 0% | 0 | 0 / 0 |
heart | 92% | 1004.62 | 794 / 861 | 0% | 0 | 0 / 0 |
muscle | 76% | 667.37 | 609 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008360 | Biological process | regulation of cell shape |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0150105 | Biological process | protein localization to cell-cell junction |
GO_0051497 | Biological process | negative regulation of stress fiber assembly |
GO_0035023 | Biological process | regulation of Rho protein signal transduction |
GO_0007264 | Biological process | small GTPase-mediated signal transduction |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0030054 | Cellular component | cell junction |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0045177 | Cellular component | apical part of cell |
GO_0005886 | Cellular component | plasma membrane |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ARHGEF18 |
Protein name | Rho/Rac guanine nucleotide exchange factor 18 Rho guanine nucleotide exchange factor 18 ARHGEF18 Rho guanine nucleotide exchange factor 18 (114 kDa Rho-specific guanine nucleotide exchange factor) (p114-Rho-GEF) (p114RhoGEF) (Septin-associated RhoGEF) (SA-RhoGEF) |
Synonyms | KIAA0521 |
Description | FUNCTION: Acts as a guanine nucleotide exchange factor (GEF) for RhoA GTPases. Its activation induces formation of actin stress fibers. Also acts as a GEF for RAC1, inducing production of reactive oxygen species (ROS). Does not act as a GEF for CDC42. The G protein beta-gamma (Gbetagamma) subunits of heterotrimeric G proteins act as activators, explaining the integrated effects of LPA and other G-protein coupled receptor agonists on actin stress fiber formation, cell shape change and ROS production. Required for EPB41L4B-mediated regulation of the circumferential actomyosin belt in epithelial cells . . |
Accessions | ENST00000594665 ENST00000617428 ENST00000668164 A0A804CAZ4 ENST00000617428.4 [Q6ZSZ5-2] ENST00000359920.11 A0A2X0SSI0 ENST00000671891.2 ENST00000319670.14 Q6ZSZ5 M0QZS0 A0A087WZG4 A0A5F9ZHI8 A0A3B3IPE9 ENST00000594665.2 [Q6ZSZ5-2] ENST00000668164.2 [Q6ZSZ5-4] A0A590UK10 |